CRISPR Therapeutics AG (CRSP)
53.51
-0.70
(-1.29%)
USD |
NASDAQ |
Jan 16, 16:00
53.54
+0.03
(+0.06%)
Pre-Market: 20:00
CRISPR Therapeutics Market Cap: 5.100B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 111.98B |
| Intellia Therapeutics, Inc. | 1.448B |
| Beam Therapeutics, Inc. | 3.168B |
| Novartis AG | 276.96B |
| BeOne Medicines Ltd. | 37.42B |
Market Cap Related Metrics
| PS Ratio | 122.05 |
| PEG Ratio | -0.0982 |
| Price to Book Value | 2.662 |
| Price | 53.51 |
| Earnings Yield | -10.43% |
| PEGY Ratio | -0.0982 |